654 Results

People

  1. Motzer
    Motzer
  2. Mulhall
    Mulhall
  3. Saltz
    Saltz
  4. Hudis
    Hudis
  5. Abou-Alfa
    Abou-Alfa
  6. Lichtman
    Lichtman
  7. De Angelis
    De Angelis
  8. Ginsberg
    Ginsberg
  9. Russo
    Russo
  10. Feldman
    Feldman

Groups

  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)
  7. Division of Subspecialty Medicine (78)
  8. Center for Hematologic Malignancies (77)
  9. Epidemiology and Biostatistics (69)
  10. Radiology, Department of (61)
  1. "hypertension"
Formats
  1. Journal Article (607)
  2. Review (31)
  3. Editorial (6)
  4. Guidelines (4)
  5. Research Letter (3)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Correspondence (1)
Groups
  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)

More Groups

People
  1. Robert Motzer (59)
  2. John Mulhall (21)
  3. Leonard Saltz (18)
  4. Clifford Hudis (16)
  5. Richard Steingart (14)
  6. Ghassan Abou-Alfa (13)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (31)
  4. 2022 (29)
  5. 2021 (23)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. Clinical Cancer Research (20)
  3. Lancet Oncology (20)
  4. Cancer (15)
  5. Journal of the National Comprehensive Cancer Network (15)
  6. Journal of Sexual Medicine (14)

More Publications

Publishers
  1. Elsevier Inc. (124)
  2. Elsevier Science, Inc. (58)
  3. Springer (47)
  4. American Society of Clinical Oncology (42)
  5. Oxford University Press (39)
  6. Wiley Blackwell (35)

More Publishers

Results (654)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: Longer-term follow-up of ASCEMBL
    Journal Article

    Hochhaus, A.; Réa, D.; Boquimpani, C.; Minami, Y.; Cortes, J. E.; Hughes, T. P.; Apperley, J. F.; Lomaia, E.; Voloshin, S.; Turkina, A.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Long-term cardiovascular burden in prostate cancer patients receiving androgen deprivation therapy
    Research Letter

    Chan, J. S. K.; Lee, Y. H. A.; Liu, K.; Hui, J. M. H.; Dee, E. C.; Ng, K.; Satti, D. I.; Tang, P.; Tse, G.; Ng, C. F.
    European Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
    Journal Article

    Yoshino, T.; Andre, T.; Kim, T. W.; Yong, W. P.; Shiu, K. K.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of transcatheter edge-to-edge repair (TEER) in patients with history of cancer
    Journal Article

    Khan, S.; Dani, S. S.; Hermann, J.; Neilan, T. G.; Lenihan, D. J.; Fradley, M.; Parikh, R.; Khan, S.; Deswal, A.; Liu, J.; more...
    International Journal of Cardiology Heart & Vasculature (2023)

    Fulltext@MSK | Save
  • Relationship between age, comorbidity, and the prevalence of erectile dysfunction
    Journal Article

    Pellegrino, F.; Sjoberg, D. D.; Tin, A. L.; Benfante, N. E.; Briganti, A.; Montorsi, F.; Eastham, J. A.; Mulhall, J. P.; Vickers, A. J.
    European Urology Focus (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
    Review

    Yang, J. C. H.; Zhou, C.; Jänne, P. A.; Ramalingam, S. S.; Kim, T. M.; Riely, G. J.; Spira, A. I.; Piotrowska, Z.; Mekhail, T.; Garcia Campelo, M. R.; more...
    Expert Review of Anticancer Therapy (2023)

    Fulltext@MSK | Save
  • Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events
    Review

    Mora, J.; Chan, G. C.; Morgenstern, D. A.; Nysom, K.; Bear, M. K.; Tornøe, K.; Kushner, B. H.
    Cancer Reports (2023)

    Fulltext@MSK | Save
  • Targeting CD19 for diffuse large B cell lymphoma in the era of CARs: Other modes of transportation
    Review

    Sermer, D.; Elavalakanar, P.; Abramson, J. S.; Palomba, M. L.; Salles, G.; Arnason, J.
    Blood Reviews (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination
    Journal Article

    Kahn, R. M.; Ragupathi, G.; Zhou, Q. C.; Iasonos, A.; Kravetz, S.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Aghajanian, C.; more...
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • Outcomes and perioperative risk factors after oncologic free-flap scalp reconstruction
    Journal Article

    Yu, J. W.; Chu, J. J.; Franck, P.; Polanco, T. O.; Shamsunder, M. G.; Teven, C. M.; Disa, J. J.; Matros, E.; Cordeiro, P. G.; Mehrara, B. J.; more...
    Journal of Reconstructive Microsurgery (2022)

    Fulltext@MSK | Save